Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
195 USD | +0.44% | +0.01% | -24.58% |
12:00pm | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.58% | 28.22B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
+54.94% | 24.64B | |
-4.99% | 16.98B | |
-34.20% | 13.29B | |
-17.85% | 11.66B | |
-12.10% | 11.65B | |
+0.15% | 8.18B | |
+5.45% | 7.78B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen Says Health Canada Accepted New Drug Submission for Alzheimer's Disease Drug Candidate